Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccines and developing countries].

G Bjune1

  • 1Avdeling for Vaksine, Statens Institutt for Folkehelse, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|May 10, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic respiratory disease in adults treated for tuberculosis in Khartoum, Sudan.

Public health action·2016
Same author

IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia.

Scandinavian journal of immunology·2013
Same author

Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Assessment of knowledge and practice about tuberculosis among eastern Ethiopian prisoners.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Evaluating an active case-finding strategy to identify smear-positive tuberculosis in rural Ethiopia.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2009
Same author

The protective role of antibody responses during Mycobacterium tuberculosis infection.

Clinical and experimental immunology·2009
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Modern gene technology can create improved vaccines to save millions of lives, addressing shortcomings of current immunizations like measles and polio vaccines. Further development is hindered by poor profit prospects in developing nations.

Area of Science:

  • Vaccinology
  • Infectious Disease Control
  • Biotechnology

Context:

  • Infectious diseases are a primary cause of death and illness in developing nations.
  • The Expanded Programme on Immunization (EPI) saves millions of lives annually but faces limitations.
  • Current vaccines have significant shortcomings in efficacy, timing, and safety.

Purpose:

  • To highlight the limitations of existing vaccines used in developing countries.
  • To explore the potential of modern gene technology and multi-vaccine-vectors for improved vaccine development.
  • To identify barriers hindering vaccine innovation for developing nations.

Summary:

  • Existing vaccines like measles, polio, and BCG have critical limitations, failing to prevent early-life deaths, posing risks, or controlling disease spread effectively.
Keywords:
Delivery Of Health CareDeveloping CountriesDiseasesEconomic FactorsHealthHealth ServicesImmunizationInfectionsMeasles--prevention and controlOrganization And AdministrationPrimary Health CareProgram EvaluationProgramsResearch And DevelopmentTechnologyTetanus--prevention and controlVaccinationVaccines--administraction and dosageViral Diseases--prevention and control

Related Experiment Videos

  • Gene technology offers a path to develop superior vaccines, potentially saving 20 million lives annually, with multi-vaccine-vectors showing particular promise.
  • Commercial interests, including low profit potential in developing countries and patent strategies, impede the advancement and accessibility of new vaccine technologies.

    • Impact:

    • Gene technology-driven vaccines could dramatically reduce mortality and morbidity from infectious diseases in developing countries.
    • Overcoming current vaccine limitations could significantly enhance global public health outcomes.
    • Addressing commercial and patent barriers is crucial for realizing the full potential of innovative vaccines for underserved populations.